Wearable giant attracts global investors as it scales a platform that turns daily data into actionable health insights.
WHOOP, the human performance company known for its sleek, screenless wristband, just landed $575 million in Series G funding at a $10.1 billion valuation. For WHOOP, it marks a step toward a future where health is continuous, personal and proactive – and where longevity isn’t just about living longer, but living better [1].
This round brings together an unusual mix of backers: Collaborative Fund led the round, joined by global investors like 2PointZero Group, Qatar Investment Authority, Mubadala Investment Company, Abbott, Mayo Clinic and individual icons such as Cristiano Ronaldo, LeBron James and Rory McIlroy. The presence of both medical heavyweights and elite athletes signals a convergence: performance and healthspan are now two sides of the same coin.
When WHOOP first launched, it was pitched as a tool for athletes, something to monitor strain, recovery, and sleep. Today, the platform aims to go further: it’s a Personal Health OS, a system that tracks physiological signals around the clock and translates them into real-life guidance.
Members use the app an average of eight times a day – checking sleep quality, recovery and daily strain – to decide whether to push harder in training, slow down or prioritize rest. But it’s not just about exercise. WHOOP’s AI looks at patterns across sleep, stress, nutrition and activity, highlighting subtle signals that can help prevent future health problems.
“Platforms like WHOOP and Oura are trying to bridge the gap between daily wellness and clinical care,” says Joe Vennare, co-founder of Fitt Insider. “It represents a future where proactive health is led by individuals, not institutions. The line between consumer tech and healthcare is starting to blur, giving people real agency over their health.”
Think of it this way: traditional healthcare is like having your car serviced once a year. WHOOP wants to be the onboard computer that monitors every turn, every tire pressure and every oil change in real time, helping you prevent breakdowns before they happen.
WHOOP isn’t just selling a wristband. It’s building a health platform with global reach, powered by more than 24 billion hours of physiological data. With this round, the company plans to expand aggressively across Europe, the Gulf, Latin America and Asia, while adding over 600 new roles to support R&D and operations.
The platform now includes features like FDA-cleared ECG, Blood Pressure Insights and Advanced Labs blood biomarker analysis, all designed to give members actionable insight without overwhelming them with data. It’s about turning numbers into decisions, and helping users make small, meaningful changes that can improve their healthspan.
“WHOOP has become one of the most important tools I use to support my long-term health,” says Cristiano Ronaldo, who also invested in the round. “No other company has created a health platform this powerful that people are proud to wear.”
The stakes for longevity
Why does this matter for longevity? Because living longer isn’t just about medicine or genetics; it’s about daily habits and early interventions. By providing a continuous stream of health data, WHOOP helps identify risks early, nudges people toward healthier behaviors and makes prevention a daily, actionable practice.
The valuation of $10.1 billion may look eye-popping, but it reflects a larger vision. The companies that succeed in longevity may not be the ones creating new drugs alone. They may be the ones that embed health into daily life, turning awareness into action and making longevity tangible and personal.
In a world where chronic diseases are rising and healthcare systems are still reactive, WHOOP’s approach feels both timely and ambitious. Health, on your wrist, every day, for years to come.
Photographs courtesy of WHOOP
[1] https://www.whoop.com/us/en/press-center/whoop-announces-series-g-funding/
